News Help Institutional access
Back to results
Bibliographic record · Consultation and access
Artículo

The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review

Joana Catarina Costa Martins et al · Federação Brasileira das Sociedades de Ginecologia e Obstetrícia · 2024

Open access available
Quick overview. Review the resource’s basic details, then access the content using the main button. This page shows only the information needed to identify, cite, and open the work.
Author / responsible party
Joana Catarina Costa Martins et al
Publisher
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
Year
2024
ISSN
0100-7203
ISSN
0100-7203
Language
English
Serial publication

A FEBRASGO e o Novo Ano

This serial publication contains 195 related contents.
View contents

Resource access

Open the content from the main option or choose another available source.

DOAJ DOAJ Articles
Entrar por DOAJ
Main access

Open access available

Recurso identificado como acceso abierto, sin confirmar automáticamente si es texto completo directo.
Open resource

Summary

Descripción general del contenido del recurso.

Abstract Objective The purpose of this study was to analyze the available evidence regarding the efficacy of iPDE5 in the treatment of female sexual dysfunction (FSD). Methods A comprehensive literature search was conducted in March 2023 through the main scientific databases. Results A total of 53 articles were identified, out of which, 6 met the predefined inclusion criteria. All of these were randomized controlled trials. Among the included studies, 4 demonstrated the effectiveness of sildenafil in improving sexual response and addressing FSD, while 2 studies failed to establish its efficacy in this context. Conclusion Overall, the efficacy of sildenafil in the treatment of FSD remains controversial and inconclusive based on the available evidence. Further research is necessary to clarify the therapeutic potential of iPDE5 in addressing FSD and to better understand the factors that influence treatment outcomes.

How to cite

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, J. C. C. M. E. (2024). The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review. https://doi.org/10.61622/rbgo/2024rbgo49

MLA

al, Joana Catarina Costa Martins et. "The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review." 2024. https://doi.org/10.61622/rbgo/2024rbgo49.

Chicago

al, Joana Catarina Costa Martins et. 2024. "The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review.". https://doi.org/10.61622/rbgo/2024rbgo49.

Harvard

al, J. C. C. M. E. 2024, The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review, Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, available at: https://doi.org/10.61622/rbgo/2024rbgo49 [Accessed 9 Aug. 2026].

Share and print

Save the record, copy its permanent link, or print it as a PDF.

Export reference

You can export the record in common formats for use in a reference manager.

RIS BibTeX

Resource details

Bibliographic information to help confirm that this is the correct material.

Title
The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review
Author / contributors
Joana Catarina Costa Martins et al
Publisher
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
Publication year
2024
ISSN
0100-7203
ISSN
0100-7203
Language
English

Subjects

Explore related resources through these subjects.

Libido; Female; Sexual dysfunction; Phosphodiesterase inhibitor; Sildenafil
Copied